Maravai Lifesciences Holdings (MRVI) Current Assets (2020 - 2026)

Maravai Lifesciences Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $251.7 million for Q1 2026.

• In Q1 2026, Current Assets fell 33.1% year-over-year to $251.7 million; the TTM figure through Mar 2026 stood at $251.7 million (down 33.1% YoY), while the FY2025 annual figure was $296.3 million, down 30.97% from the prior year.
• Current Assets was $251.7 million for Q1 2026 at Maravai Lifesciences Holdings, down from $296.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $847.9 million in Q4 2022 to a low of $251.7 million in Q1 2026.
• Historically, Current Assets has averaged $587.9 million across 5 years, with a median of $679.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Current Assets surged 45.49% in 2022, then tumbled 52.02% in 2025.
• A 5-year view of Current Assets shows it stood at $847.9 million in 2022, then slipped by 17.45% to $699.9 million in 2023, then tumbled by 38.69% to $429.1 million in 2024, then sank by 30.97% to $296.3 million in 2025, then retreated by 15.03% to $251.7 million in 2026.
• The last three Current Assets figures came in at $251.7 million (Q1 2026), $296.3 million (Q4 2025), and $325.9 million (Q3 2025), per Business Quant data.